
Affiliated with a Castle Connolly Top Hospital
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
Also known as:
ICD-10 Codes:
For detailed information, please contact Dr. Fan's office.
All Other Third Party
AllCare Health Plan
Blue Shield of California
Centene
Central California Alliance for Health
CVS Health (formerly Aetna)
Express Scripts
Medicaid
Medicare
UnitedHealthcare
View All Insurances
Picolog, a Synthetically-Available Bryostatin Alog, Inhibits Growth of MYC-Induced Lymphoma In Vivo
ONCOTARGET, 2012
nofluidic proteomic assay for serial alysis of oncoprotein activation in clinical specimens
TURE MEDICINE, 2009
Supramolecular Stacking of Doxorubicin on Carbon notubes for In Vivo Cancer Therapy
ANGEWANDTE CHEMIE-INTERTIOL EDITION, 2009
A quantitative PCR method to detect blood microRs associated with tumorigenesis in transgenic mice
MOLECULAR CANCER, 2008
Combined Ictivation of MYC and K
PLOS ONE, 2008
Apoptosis-stimulating protein of p53
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2009
Cellular senescence is an important mechanism of tumor regression upon c-Myc ictivation
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2007
Sustained regression of tumors upon MYC ictivation requires p53 or thrombospondin
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2006
Conditiol animal models
SEMIRS IN CANCER BIOLOGY, 2004
Treatment of higher risk myelodyspl
LEUKEMIA RESEARCH, 2012
Picolog, a Synthetically-Available Bryostatin Analog
ONCOTARGET, 2012
Nanofluidic proteomic assay for serial analysis of oncoprotein activation in clinical specimens
NATURE MEDICINE, 2009
Supramolecular Stacking of Doxorubicin on Carbon Nanotubes for In Vivo Cancer Therapy
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009
A quantitative PCR method to detect blood microRNAs associated with tumorigenesis
MOLECULAR CANCER, 2008
Combined Inactivation of MYC and K
PLOS ONE, 2008
BCL-2 inhibition with ABT-737 prolongs survival in an NRAS
Blood, 2013
A c-Myc Activation Sensor
Molecular cancer therapeutics, 2013
Cryptococcal osteomyelitis
BMJ case reports, 2012
Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
CANCER RESEARCH, 2010
CD4(+) T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor
CANCER CELL, 2010
Apoptosis-stimulating protein of p53
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2009
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis
BLOOD, 2007
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2007
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2006
Conditional animal models
SEMINARS IN CANCER BIOLOGY, 2004
p53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma
CANCER, 2000